Author

E. Vendrame

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Assay:flow cytometry· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

T. Ranganath· 3 shared C. A. Blish· 2 shared C. Seiler· 2 shared L. J. Simpson· 2 shared N. Q. Zhao· 2 shared A. C. Labbe· 1 shared A. Leibar· 1 shared A. Linares· 1 shared

Activity by Year

2019-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

T. Ranganath

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

CyTOF analysis identifies unusual immune cells in urine of BCG-treated bladder cancer patients

E. Castellano, C. Samba, G. Esteso, L. J. Simpson, E. Vendrame, E. M. Garcia-Cuesta, S. Lopez-Cobo, M. Alvarez-Maestro, A. Linares, A. Leibar, T. Ranganath, H. T. Reyburn, L. Martinez-Pineiro, C. Blish, M. Vales-Gomez

The paper uses CyTOF to identify a novel immune cell population in urine of BCG-treated bladder cancer patients, linking it to inflammatory response and potential treatment risk.

bioRxiv · Jun 12, 2020Immunology

Characterization of the impact of daclizumab beta on circulating natural killer cells by mass cytometry

T. Ranganath, L. J. Simpson, C. Seiler, A.-M. Ferreira, E. Vendrame, N. Q. Zhao, J. D. Fontenot, S. P. Holmes, C. A. Blish

This study uses mass cytometry to analyze how daclizumab beta affects NK cell phenotypes in RMS patients, showing distinct changes in CD56bright and CD56dim subsets.

bioRxiv · Dec 5, 2019Immunology

TIGIT is upregulated by HIV-1 infection and marks a highly functional adaptive and mature subset of natural killer cells

E. Vendrame, C. Seiler, T. Ranganath, N. Q. Zhao, R. Vergara, M. Alary, A. C. Labbe, F. Guedou, J. Poudrier, S. Holmes, M. Roger, C. A. Blish

This study shows that TIGIT is upregulated on NK cells in untreated HIV+ individuals and marks a functional, mature NK cell subset with enhanced responses to HIV-infected targets.

bioRxiv · Sep 10, 2019Immunology